Literature DB >> 20500233

'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients.

N Bourgeois1, P Bastien, J Reynes, A Makinson, I Rouanet, L Lachaud.   

Abstract

OBJECTIVES: The aim of the study was to describe a new evolutionary form of visceral leishmaniasis observed in immunocompromised patients.
METHODS: We carried out long-term clinical and biological follow-up of 10 HIV-1/Leishmania-coinfected patients presenting numerous secondary visceral leishmaniasis episodes despite treatment, with the follow-up time ranging from 0.5 to 10 years.
RESULTS: Analysis of polymerase chain reaction (PCR) and blood culture results demonstrated continuous multiplication and circulation of parasites despite treatment, both during asymptomatic periods and during secondary visceral leishmaniasis episodes. This condition may be termed 'chronic' because of the presence of relapses over a period of several years and 'active' because of the continuous blood circulation of the parasite.
CONCLUSION: We wish to define 'active chronic visceral leishmaniasis' as a novel nosological entity observed in HIV-1/Leishmania-coinfected patients. © British HIV Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20500233     DOI: 10.1111/j.1468-1293.2010.00846.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  31 in total

1.  Hepatopulmonary syndrome associated with visceral leishmaniasis.

Authors:  Nihal Martis; Christelle Pomares; Pierre Yves Jeandel; Thierry Lazure; Pierre Marty; Eric Rosenthal
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  Renal leishmaniasis as unusual cause of nephrotic syndrome in an HIV patient.

Authors:  Kerstin Amann; Christian Bogdan; Thomas Harrer; Juergen Rech
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

3.  New challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas.

Authors:  Kathryn M Dupnik; Eliana L Nascimento; Joao F Rodrigues-Neto; Tatjana Keesen; Maria Zélia Fernandes; Iraci Duarte; Selma M B Jeronimo
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

4.  Human Competence to Transmit Leishmania infantum to Lutzomyia longipalpis and the Influence of Human Immunodeficiency Virus Infection.

Authors:  Gabriel Reis Ferreira; José Carlos Castelo Branco Ribeiro; Antônio Meneses Filho; Teresinha de Jesus Cardoso Farias Pereira; Daniela Moura Parente; Humberto Feitosa Pereira; Jailthon Carlos da Silva; Danielle Alves Zacarias; Letiano Vieira da Silva; Symonara Karina Medeiros Faustino; Walfrido Salmito Almeida Neto; Dorcas Lamounier Costa; Ivete Lopes de Mendonça; Carlos Henrique Nery Costa
Journal:  Am J Trop Med Hyg       Date:  2018-01       Impact factor: 2.345

5.  Ultrasensitive real-time PCR for the clinical management of visceral leishmaniasis in HIV-Infected patients.

Authors:  Israel Molina; Roser Fisa; Cristina Riera; Vicenç Falcó; Aleix Elizalde; Fernando Salvador; Manuel Crespo; Adrian Curran; Paulo López-Chejade; Silvia Tebar; Santiago Pérez-Hoyos; Esteban Ribera; Albert Pahissa
Journal:  Am J Trop Med Hyg       Date:  2013-04-29       Impact factor: 2.345

6.  Visceral Leishmaniasis in Hospitalized HIV-Infected Patients in Pernambuco, Brazil.

Authors:  Diego Lins Guedes; Zulma Medeiros; Elis Dionísio da Silva; Audrey Violeta Martins de Vasconcelos; Mariana Santana da Silva; Maria Almerice Lopes da Silva; Paulo Sérgio Ramos de Araújo; Demócrito de Barros Miranda-Filho
Journal:  Am J Trop Med Hyg       Date:  2018-12       Impact factor: 2.345

Review 7.  Leishmaniasis: new insights from an old and neglected disease.

Authors:  S Antinori; L Schifanella; M Corbellino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

8.  Human immunodeficiency virus infection and the liver.

Authors:  Megan Crane; David Iser; Sharon R Lewin
Journal:  World J Hepatol       Date:  2012-03-27

9.  Visceral leishmaniasis revealed by a squamous cell carcinoma in an HIV-1 infected patient.

Authors:  P Donati; G Paolino; C Panetta; L Muscardin; C Cota; M Giuliani
Journal:  Infection       Date:  2013-02-03       Impact factor: 3.553

10.  Polymerase Chain Reaction in the Diagnosis of Visceral Leishmaniasis Recurrence in the Setting of Negative Splenic Smears.

Authors:  Golam Hasnain; Ariful Basher; Proggananda Nath; Prakash Ghosh; Faria Hossain; Shakhawat Hossain; Dinesh Mondal
Journal:  Am J Trop Med Hyg       Date:  2015-11-10       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.